Bipolar Disorder Clinical Trials in Philadelphia

Showing 81-98 of 98 trials

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

NCT00090311

The purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of children and adolescent patients with Bipolar I mania.

Bipolar Disorder

AstraZeneca220 participantsStarted Jul 2004

Scottsdale, Arizona, United States • Riverside, California, United States • Sacramento, California, United States +29 more locations

COMPLETEDPhase 3< 1 mile

Seroquel in Bipolar Depression Versus SSRI

NCT00119652

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.

Bipolar DisorderBipolar DepressionDepression

AstraZeneca676 participantsStarted May 2005

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • National City, California, United States +52 more locations

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Seroquel in Bipolar Depression Versus SSRI

Bipolar Disorder Trials in Other Cities

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression

Other Conditions in Philadelphia